JSP191 Antibody Targeting Conditioning in SCID Patients
Clinical trial NCT02963064 · TERMINATED
Trial details
- NCT number
- NCT02963064
- Sponsor
- Jasper Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2025-07-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.